Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer

Summary

Phase II trial to study the effectiveness of bevacizumab combined with vinorelbine in treating patients who have stage IV breast cancer. Monoclonal antibodies such as bevacizumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining monoclonal antibody with chemotherapy may kill more cancer cells

Timeline

Start

2001-03

Primary completion

2007-09

Completion

—

Drugs

Indications